Angioneurotic Edema Completed Phase 2 / 3 Trials for Conestat alfa (DB09228)

Also known as: Angioneurotic oedema / Allergic angioedema / Allergic angioedema (disorder) / Angioedema (morphologic abnormality) / Oedema angioneurotic / Quincke's edema / Angioedema / Angioedema (disorder) / Angioedemas / Edema angioneurotic / Angioedema and urticaria / Angio-edema / Oedema Quincke's / Quincke's oedema / Giant urticaria / Edema Quincke's / Urticaria giant / Giant urticaria (disorder) / Giant hives / Hives giant

IndicationStatusPhase
DBCOND0031400 (Angioneurotic Edema)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00225147
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary AngioedemaTreatment